Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Western medicine compound preparation for treating colitis

A technology for compound preparations and colitis, which is applied in the direction of medical formulas, medical preparations containing active ingredients, drug combinations, etc., can solve the problems of delayed disease, long treatment course, high treatment cost, etc., and achieves short treatment course, simple preparation method, The effect of low treatment cost

Inactive Publication Date: 2017-05-17
HENAN BALING ELECTRONICS TECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] The treatment of colitis is mostly treated with antibiotics and infusion. The treatment course is long and the treatment cost is high. Many patients delay their condition due to lack of timely treatment.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] A western medicine compound preparation for treating colitis, comprising the following raw materials in parts by weight: 5 parts of taurine, 8 parts of cysteine, 5 parts of methionine, 0.05 parts of metformin, 0.05 parts of phenformin, 2 parts of L-carnitine 10 parts of piperazine ferulic acid, 15 parts of captopril, 2 parts of Imogen, 2 parts of chitosan, 1 part of cisapride, 1 part of Nuanwei Shule tablets, and 0.01 part of vitamin B1.

[0033] A preparation method of a western medicine compound preparation for treating colitis, comprising the following steps:

[0034] (1) each raw material is weighed according to parts by weight in a sterile room, for subsequent use;

[0035] (2) After grinding taurine, metformin, phenformin, and captopril into powder, mix them uniformly at a temperature of 25° C. to obtain mixture A;

[0036] (3) After grinding cysteine, methionine, L-carnitine, imastatine ferulate, and cisapride into powder, mix them uniformly at a temperature of ...

Embodiment 2

[0040] A western medicine compound preparation for treating colitis, comprising the following raw materials in parts by weight: 10 parts of taurine, 10 parts of cysteine, 8 parts of methionine, 0.2 parts of metformin, 0.1 part of phenformin, 5 parts of L-carnitine 20 parts of piperazine ferulic acid, 20 parts of captopril, 5 parts of Imogen, 5 parts of chitosan, 5 parts of cisapride, 2 parts of Nuanwei Shule tablets, and 0.05 parts of vitamin B1.

[0041] A preparation method of a western medicine compound preparation for treating colitis, comprising the following steps:

[0042] (1) each raw material is weighed according to parts by weight in a sterile room, for subsequent use;

[0043] (2) taurine, metformin, phenformin and captopril are ground into powder and mixed uniformly at a temperature of 40°C to obtain mixture A;

[0044] (3) After grinding cysteine, methionine, L-carnitine, imastatine ferulate, and cisapride into powder, mix them uniformly at a temperature of 50° C...

Embodiment 3

[0048] A western medicine compound preparation for treating colitis, comprising the following parts by weight of raw materials: 8 parts of taurine, 9 parts of cysteine, 7 parts of methionine, 0.1 part of metformin, 0.08 part of phenformin, 3 parts of L-carnitine 15 parts of piperazine ferulic acid, 16 parts of captopril, 3 parts of Imogen, 4 parts of chitosan, 3 parts of cisapride, 1.2 parts of Nuanwei Shule tablets, and 0.03 parts of vitamin B1.

[0049] A preparation method of a western medicine compound preparation for treating colitis, comprising the following steps:

[0050] (1) each raw material is weighed according to parts by weight in a sterile room, for subsequent use;

[0051] (2) The taurine, metformin, phenformin, and captopril are ground into powder, and then mixed uniformly at a temperature of 29° C. to obtain mixture A.

[0052] (3) Cysteine, methionine, L-carnitine, imidate piperazine ferulate, and cisapride are ground into powder, and then mixed uniformly at...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a western medicine compound preparation for treating colitis. The western medicine compound preparation for treating colitis is prepared from the following raw materials in parts by weight: 5-10 parts of taurine, 8-10 parts of cysteine, 5-8 parts of methionine, 0.05-0.2 part of metformin, 0.05-0.1 part of phenformin, 2-5 parts of L-carnitine, 10-20 parts of piperazine ferulate, 15-20 parts of captopril, 2-5 parts of imodium, 2-5 parts of chitosan, 1-5 parts of cisapride, 1-2 parts of Nuanwei Shule Tablet and 0.01-0.05 part of vitamin B1. The western medicine compound preparation disclosed by the invention has a better effect on treating colitis, and the effective rate reaches 98%; by compounding multiple raw materials and playing synergistic effects, the effects of strengthening the spleen and stomach as well as checking diarrhea and strengthening the intestines can be achieved; and meanwhile, a preparation method is simple, the treatment cost is low, the treatment course is short, toxic and side effects are less, and adverse effects are less.

Description

technical field [0001] The invention relates to the technical field of western medicine preparation, in particular to a western medicine compound preparation for treating colitis. Background technique [0002] Colitis (diarrhea) is a common clinical symptom that can be caused by a variety of diseases. Normal people defecate once a day, and the amount of feces excreted is about 200-400g. There are also a small number of people who defecate 2 to 3 times a day, but the stool is normal, so it cannot be called colitis. Colitis generally refers to an increase in the number of bowel movements or frequent defecation per day, the stool is thin or contains mucus, pus and blood, or also contains indigestible food and other pathological contents. Colitis is generally divided into two categories: acute colitis and chronic colitis. The former refers to the acute onset of colitis and lasts for a short time, while the latter generally refers to those who have colitis for more than 2 month...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9068A61K31/722A61K31/185A61K31/198A61K31/155A61K31/205A61K31/192A61K31/495A61K31/401A61K31/451A61K31/4468A61K31/51A61P1/00A61P1/12A61K36/481A61K36/71A61K36/537A61K36/484A61K36/898A61K36/9064A61K36/66A61K36/74A61K36/185A61K36/54A61K35/64
CPCA61K36/898A61K36/9064A61K36/9068A61K31/155A61K31/185A61K31/192A61K31/198A61K31/205A61K31/401A61K31/4468A61K31/451A61K31/495A61K31/51A61K31/722A61K35/63A61K36/185A61K36/481A61K36/484A61K36/537A61K36/54A61K36/66A61K36/71A61K36/74A61K2300/00
Inventor 不公告发明人
Owner HENAN BALING ELECTRONICS TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com